Source: Eur Respir J 2011; 38: 1221-1223



Rating:

Share or cite this content

Citations should be made in the following way:
Sotgiu G., D’Ambrosio L., Centis R., Bothamley G., Cirillo D.M., De Lorenzo S., Guenther G., Kliiman K., Muetterlein R., Spinu V., Villar M., Zellweger J.P., Sandgren A., Huitric E., Lange C., Manissero D., Migliori G.B.. TB and M/XDR-TB infection control in European TB reference centres: the Achilles’ heel?. Eur Respir J 2011; 38: 1221-1223

Member's Comments

No comment yet.

Related content which might interest you: Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control Source: Eur Respir J, 50 (1) 1700004; 10.1183/13993003.00004-2017 Year: 2017 The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Source: Eur Respir J 2011; 38: 1374-1381 Year: 2011 Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection Source: International Congress 2017 – Migrants and screening Year: 2017 Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 TB "cross-border" - a new challenge in tuberculosis management Source: Virtual Congress 2020 – Tuberculosis and society Year: 2020 An audit of diagnosis and chemoprophylaxis treatment of latent tuberculosis Infection (LTBI) in TB contact patients in a district general hospital (DGH) in the United Kingdom (UK) Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010 Number of tuberculosis (TB) cases reported by primary care physicians (PCPs) in India: Results of a 1-day point prevalence study in 880 urban cities and towns in India Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Control of MDR-/XDR-TB and elimination of TB in Europe: status update Source: Annual Congress 2012 - Fighting MDR- and XDR-TB in Europe: from programme results to research implementation Year: 2012 Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate? Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Treatment outcome among HIV positive and HIV negative TB patients in Chandigarh, India: A retrospective cohort study Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Romanian TB patients working abroad: an unknown problem for EU Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008 Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement Source: Eur Respir J 2012; 40: 1081-1090 Year: 2012 Prevalence of latent tuberculosis infection among household contacts and community controls in South India Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Was DOT really effective in TB endemia control in Romania? Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents Year: 2008 Experience of managing TB/HIV infection in a regional UK center over a 5 year period Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Active case-finding of tuberculosis in Europe Source: Annual Congress 2007 - Clinical epidemiology of tuberculosis Year: 2007